uspto-grants-2004_06 · 10.6084/m9.figshare.5104873.v1 · US06747022B2
查看IDENTITY
结构与身份
- 标准SMILES
- CC(C)(C)C(=O)CN1C(=O)[C@H](NC(=O)Nc2cccc(C(=O)O)c2)CN(C2CCCCC2)c2ccccc21
- InChIKey
- VIJCCFFEBCOOIE-JOCHJYFZSA-N
- 分子式
- C29H36N4O5
- 平均分子量
- 520.6 g/mol
- 单同位素质量
- 520.26857026
COMPUTED
结构计算性质
- XLogP
- 4.4
- 极性表面积
- 119 Ų
- 氢键供体
- 3
- 氢键受体
- 6
- 可旋转键
- 7
- 重原子
- 38
- 形式电荷
- 0
- 复杂度
- 881
ALIASES
名称与别名
Z-3603-[[(3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid3-(((3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl)carbamoylamino)benzoic acidRefChem:195806Nastorazepide209219-38-5Nastorazepide (Z-360)Z-360 free acidR22TMY97SGZ 360(R)-3-(3-(5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acidR-(-)-Z-360 Free acidZ360Benzoic acid, 3-(((((3R)-5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2,3,4,5-tetrahydro-2-oxo-1H-1,5-benzodiazepin-3-yl)amino)carbonyl)amino)-MFCD26142609Z360; NastorazepideUNII-R22TMY97SGNASTORAZEPIDE [INN]GTPL907NASTORAZEPIDE [WHO-DD]
REACTIONS
参与反应
uspto-grants-2001_05 · 10.6084/m9.figshare.5104873.v1 · US06239131B1
查看